Abstract
One mechanism by which estrogen may modulate cognitive function is through potentiation of glutamate-mediated rises in intracellular calcium ([Ca2+]i) with resultant effects on neuronal morphology and signaling. Since progesterone is a component of hormone replacement therapy (HRT), we sought to determine whether therapeutically relevant progestins attenuated or blocked estrogen potentiation of glutamate-induced [Ca2+]i rises. 17β-estradiol and progesterone, alone or in combination, significantly potentiated the rise in [Ca2+]i. When co-administered, progesterone attenuated the estrogen response to the level seen with progesterone alone. In contrast, medroxyprogesterone acetate (MPA) had no effect when administered alone and completely blocked the 17β-estradiol-induced potentiation when co-administered. These results may have important implications for effective use of HRT to maintain cognitive function during menopause and aging.
Original language | English (US) |
---|---|
Pages (from-to) | 825-830 |
Number of pages | 6 |
Journal | NeuroReport |
Volume | 13 |
Issue number | 6 |
DOIs | |
State | Published - May 7 2002 |
Externally published | Yes |
Keywords
- Calcium
- Cognitive function
- Estrogen
- Glutamate
- Hormone replacement therapy
- Neuron
- Progesterone
ASJC Scopus subject areas
- General Neuroscience